Efficacy and safety of non‐vitamin K antagonist oral anticoagulants versus warfarin in atrial fibrillation and kidney failure under hemodialysis: A meta‐analysis of controlled randomized trials
Our results suggest that NOACs (rivaroxaban or apixaban) are as safe and effective as VKAs in patients with AF and kidney failure with hemodialysis. Even on oral anticoagulants, these patients remain at high risk of cardiovascular events and all-cause mortality. Integrated care and holistic management are important for this high-risk population.
Authors
- Fa‐Po Chung (ORCID: https://orcid.org/0000-0001-8960-1301)
- Tze‐Fan Chao (ORCID: https://orcid.org/0000-0002-6587-3094)
- Yu‐Feng Hu (ORCID: https://orcid.org/0000-0001-5715-2070)
- Li‐Wei Lo (ORCID: https://orcid.org/0000-0001-9102-227X)
- Yenn‐Jiang Lin (ORCID: https://orcid.org/0000-0001-8395-1052)
- Chin‐Yu Lin (ORCID: https://orcid.org/0000-0003-3282-7523)
- Yi‐Hsin Chan (ORCID: https://orcid.org/0000-0002-1406-8503)
- Ting‐Yung Chang (ORCID: https://orcid.org/0000-0002-2612-0057)
- Shih‐Ann Chen (ORCID: https://orcid.org/0000-0001-9085-0823)
Institutions
- National Yang Ming Chiao Tung University (TW)
- National Chung Hsing University (TW)
- Chang Gung University (TW)
- National Taipei University of Nursing and Health Science (TW)
- Taipei Veterans General Hospital (TW)
- Chang Gung Memorial Hospital (TW)
- Taichung Veterans General Hospital (TW)
Publication Details
- Journal
- Journal of Arrhythmia
- Published
- 2025-05-19
- DOI
- https://doi.org/10.1002/joa3.70094
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Shanghai Educational Development Foundation
- Taipei Veterans General Hospital